Double-blinded, placebo-controlled trial on intravenous l-alanyl-l-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 5, 2006, Pages 1330-1337

  Cerchietti, Leandro C A ^a   Navigante, Alfredo H ^a   Lutteral, Maribel A ^a   Castro, Monica A ^a   Kirchuk, Ricardo ^a   Bonomi, Marcelo ^a   Cabalar, Maria Esther ^a   Roth, Berta ^a   Negretti, Graciela ^a   Sheinker, Beatriz ^a   Uchima, Patricia ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Chemoradiation; Glutamine; Head and neck cancer; Mucositis

Indexed keywords

AMINO ACIDS; CHEMOTHERAPY; MEDICAL PROBLEMS; PATIENT MONITORING; RADIATION EFFECTS; RADIOTHERAPY; TUMORS;

CHEMORADIATION; CHEMORADIOTHERAPY; GLUTAMINE; HEAD CANCER; MUCOSITIS; NECK CANCER; OBJECTIVE MUCOSITIS SCORE (OMS);

ONCOLOGY;

ALANYLGLUTAMINE; CISPLATIN; FLUOROURACIL; NARCOTIC ANALGESIC AGENT; PLACEBO; SODIUM CHLORIDE; ANTINEOPLASTIC AGENT; DIPEPTIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEEDING APPARATUS; HEAD AND NECK CANCER; HUMAN; INCIDENCE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; WORLD HEALTH ORGANIZATION; DRUG EFFECT; HEAD AND NECK TUMOR; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MOUTH MUCOSA; RADIATION EXPOSURE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DIPEPTIDES; DOUBLE-BLIND METHOD; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS, INTRAVENOUS; MIDDLE AGED; MOUTH MUCOSA; STOMATITIS;

EID: 33748533475     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.03.042     Document Type: Article

References (27)

1. Seiwert T., and Cohen E. State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 92 (2005) 1341-1348
2. Vermorken J. Medical treatment in head and neck cancer. Ann Oncol 16 (2005) ii258-ii264
3. Merlano M., and Marchetti G. Radiochemotherapy in head and neck cancer. Cancer Treat Rev 29 (2003) 291-296
4. Brizel D., Albers M., Fischer S., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338 (1998) 1798-1804
5. Trotti A., Bellm L., Epstein J., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy. A systematic literature review. Radiother Oncol 66 (2003) 253-262
6. Giglio R., Mickiewicz E., Pradier R., et al. Sustained high complete response with an intensive treatment of concurrent chemoradiotherapy for oropharynx cancer [abstract]. J Clin Oncol 21 (2002) 238a ASCO Annual Meeting Proceedings
7. Duncan M., and Grant G. Review article. Oral and intestinal mucositis-causes and possible treatments. Aliment Pharmacol Ther 18 (2003) 853-874
8. Lacey J., and Wilmore D. Is glutamine a conditionally essential amino acid?. Nutr Rev 48 (1990) 297-309
9. Kubota A., Meguid M., and Hitch D. Amino acid profiles correlate diagnostically with organ site in three kinds of malignant tumors. Cancer 69 (1992) 2343-2348
10. Neu J., DeMarco V., and Li N. Glutamine. Clinical applications and mechanisms of action. Curr Opin Clin Nutr Metab Care 5 (2002) 69-75
11. Savarese D., Savy G., Vahdat L., et al. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 29 (2003) 501-513
12. Albert S., Wernerman J., Stehle P., et al. Availability of amino acids supplied intravenously in healthy man as synthetic dipeptides. Kinetic evaluation of l-alanyl-l-glutamine and glycyl-l-tyrosine. Clin Sci 75 (1988) 463-468
13. Bai M., Jiang Z., Liu Y., et al. Effects of alanyl-glutamine on gut barrier function. Nutrition 12 (1996) 793-796
14. Decker-Baumann C., Buhl K., Frohmuller S., et al. Reduction of chemotherapy-induced side-effects by parental glutamine supplementation in patients with metastatic colorectal cancer. Eur J Cancer 35 (1999) 202-207
15. World Health Organization. Handbook for reporting results of cancer treatment (1979), WHO, Geneva, Switzerland 15-22
16. Sonis S., Eilers J., Epstein J., et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer Treat Rev 85 (1999) 2103-2113
17. Oken M., Creech R., Tormey D., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
18. Huang E., Wan Leung S., Wang C., et al. Oral glutamine to alleviate radiation-induced oral mucositis. A pilot randomized trial. Int J Radiat Oncol Biol Phys 46 (2000) 535-539
19. Anderson P., Schroeder G., and Skubitz K. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 83 (1998) 1433-1439
20. Okuno S., Woodhouse C., Loprinzi C., et al. Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy. Am J Clin Oncol 22 (1999) 258-261
21. Jebb S., Osborne R., Maughan T., et al. 5-fluorouracil and folinic acid-induced mucositis. No effect of oral glutamine supplementation. Br J Cancer 70 (1994) 732-735
22. Curi R., Lagranha C., Doi S., et al. Molecular mechanisms of glutamine action. J Cell Physiol 204 (2005) 392-401
23. Sonis S. The pathobiology of mucositis. Nature Rev Cancer 4 (2004) 277-284
24. Carneiro-Filho B., Oria R., Wood Rea K., et al. Alanyl-glutamine hastens morphologic recovery from 5-fluorouracil-induced mucositis in mice. Nutrition 20 (2004) 934-941
25. Chen M.K., Salloum R.M., Austgen T.R., et al. Tumor regulation of hepatic glutamine metabolism. J Parenter Enteral Nutr 15 (1991) 159-164
26. Erickson R., Ross D., and Medina J. Effects of glutamine on head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 121 (1999) 348-354
27. Rouse K., Nwokedi E., Woodliff J., et al. Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Ann Surg 221 (1995) 420-426